Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_assertion type Assertion NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_head.
- NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_assertion description "[We assessed the antitumoral effects of orlistat against the human breast cancer cell line SK-Br3, an in vitro paradigm of FAS and Her2/neu overexpression in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_provenance.
- NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_assertion evidence source_evidence_literature NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_provenance.
- NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_assertion SIO_000772 15870086 NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_provenance.
- NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_assertion wasDerivedFrom befree-2016 NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_provenance.
- NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_assertion wasGeneratedBy ECO_0000203 NP493004.RA_qgngoUhRd1l0O_3URyMxMJfhXA7n6xzS-bcLrMDbbU130_provenance.